Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P10721 (
c-kit
)
6,575
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Literature data suggest that inflammatory cells such as mast cells (MCs) are involved in angiogenesis. MCs can stimulate angiogenesis by releasing of well identified pro-angiogenic cytokines stored in their cytoplasm. In particular, MCs can release tryptase, a potent
in vivo
and
in vitro
pro-angiogenic factor. Nevertheless, few data are available concerning the role of MCs positive to tryptase in primary pancreatic cancer angiogenesis. This study analyzed the correlation between mast cells positive to
c-Kit
receptor (
c-Kit
+
MCs), the density of MCs expressing tryptase (
MCD
-T) and microvascular density (MVD) in primary tumor tissue from patients affected by pancreatic ductal adenocarcinoma (PDAC). A series of 35 PDAC patients with stage T
2-3
N
0-1
M
0
(by AJCC for Pancreas Cancer Staging 7
th
Edition) were selected and then undergone to surgery. Tumor tissue samples were evaluated by mean of immunohistochemistry and image analysis methods in terms of number of
c-Kit
+
MCs,
MCD
-T and MVD. The above parameters were related each other and with the most important main clinico-pathological features. A significant correlation between
c-Kit
+
MCs,
MCD
-T and MVD groups each other was found by Pearson t-test analysis (r ranged from 0.75 to 0.87; p-value ranged from 0.01 to 0.04). No other significant correlation was found. Our
in vivo
preliminary data, suggest that tumor microenvironmental MCs evaluated in terms of
c-Kit
+
MCs and
MCD
-T may play a role in PDAC angiogenesis and they could be further evaluated as a novel tumor biomarker and as a target of anti-angiogenic therapy.
...
PMID:The density of mast cells c-Kit
+
and tryptase
+
correlates with each other and with angiogenesis in pancreatic cancer patients. 2905 Feb 94
